Background: In this era, worldwide interest has been directed towards using natural antioxidants to guard against drug side effects. Saussurea lappa is a famous medicinal plant with many biologically active compounds. Triamcinolone acetonide (TA) is an extensively used glucocorticoid. Hence, this study explored, for the first time, the possible beneficial effects of S. lappa ethanolic extract on TA-induced oxidative damage in the lung and spleen of rats. Methods: Five experimental groups were used: control group, S. lappa-treated group (600 mg/kg/day, orally), TA-treated group (40 mg/kg/twice/week I/P), S. lappa + TA co-treated group, and S. lappa/TA prophylactic group. Results: TA exposure significantly induced leukocytosis and neutrophilia. In addition, TA significantly reduced the levels of C-reactive protein, interleukin-12, tumor necrosis factor α, and immunoglobulins. Lung Caspase-3 overexpression and splenic CD8+ downregulation were also noted in the TA group. TA treatment significantly increased malondialdehyde concentration but reduced superoxide dismutase and glutathione peroxidase activities. S. lappa counteracted the TA oxidative and apoptotic effects. The best results were recorded in the prophylactic group. Conclusions: S. lappa has a remarkable protective effect via its anti-inflammatory, anti-apoptotic, and antioxidant capacity. Thus, it could be a candidate as a natural antioxidant to face glucocorticoid’s harmful side effects.

No abstract

The present study was conducted to investigate the effect of graded levels of dietary bentonite supplementation on growth performance, carcass traits, nutrient digestibility, and histopathology of certain organs in rabbits fed a diet naturally contaminated with aflatoxin. In total, 125 weanling New Zealand White male rabbits were randomly assigned to five treatment groups each of five replicates. Treatments were as follows: T1, basal diet with no aflatoxin and no additives (positive control diet, PCD); T2, basal diet naturally contaminated with 150 ppb aflatoxin and no additives (negative control diet, NCD); T3, NCD plus 0.5% Egyptian bentonite; T4, NCD plus 1% Egyptian bentonite; and T5, NCD plus 1% Egyptian bentonite. The experiment lasted for 8 weeks. Results showed a significant decrease (P < 0.05) in the body weight and the body weight gain in the NCD, while they were improved (P < 0.05) in groups fed diets supplemented with different levels of bentonite. The relative weight of the liver and kidneys were higher in the NCD, while the liver weight was relatively high in the group fed NCD supplemented with 0.5% bentonite, and it was not significant in other bentonite-supplemented groups. Bentonite supplementation improved the digestibility coefficients of various nutrients. Bentonite addition decreased the histopathological lesions in liver, kidney, and intestine caused by aflatoxin-infected diets. In conclusion, bentonite supplementation overcame the negative effect of aflatoxin, enhanced growth performance traits, decreased the relative weights of the liver and the kidney which are usually increased by aflatoxin, caused significant improvement in nutrients' digestibility, and decreased the histopathological lesions caused by aflatoxin-infected diets. The level of 2% bentonite is recommended for ameliorating the aflatoxin effects.

No abstract

Background and Aim: Signs of dysautonomia were frequently observed in calves that died during foot-and-mouth disease (FMD) virus (FMDV) outbreaks in Egypt from 2015 to 2018. This study aimed to describe the clinical and histopathological features of the central nervous system in malignant cases of FMD and excluding possible concurrent bacterial, and bovine herpes virus 4 (BHV4) infections or both. Materials and Methods: In this study, 335 FMDV-infected buffalo calves aged 1-22 months were clinically examined and followed until recovery or death. Of the 335 calves, 134 died (malignant group) and 201 recovered after exhibiting classic symptoms of FMD (recover group). The calves were subjected to clinical examination. For the malignant group, several laboratory trials were conducted to assess the possible cause/s of dysautonomia-related viral, bacterial, or concurrent infections. Koch's postulates and polymerase chain reaction were employed. Postmortem and histopathological examinations of nervous tissue were performed. Results: In the malignant group, signs of dysautonomia were observed before death, including partial or complete gut dysfunction, loss of anal sphincter tone, rapid breathing sounds, fluctuating body temperature, and cardiac arrhythmias. In the malignant group, histopathological examination of the spinal cord, pons, medulla oblongata, hypothalamus, cerebellum, and cerebrum revealed demyelination, neuronal degeneration, and focal areas of malacia and gliosis. The nervous tissue and heart samples from malignant cases were positive for serotype O FMDV. Conclusion: Findings revealed in this study support the existence of neurodegeneration induced by FMDV infection in buffalo calves.